Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

CureVac NV (5CV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.35 -0.08    -3.21%
13:22:33 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  NL0015436031 
S/N:  A2P71U
  • Volume: 7,871
  • Bid/Ask: 2.29 / 2.31
  • Day's Range: 2.33 - 2.44
CureVac NV 2.35 -0.08 -3.21%

Curevac NV Company Profile

 
Get an in-depth profile of CureVac NV, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

824

Equity Type

ORD

CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.

Contact Information

Address Friedrich-Miescher-Strasse 15
Tübingen, 72076
Germany
Phone 49 7071 9883 0
Fax 49 7071 9883 1101

Top Executives

Name Age Since Title
Baron Jean Stephenne 72 2015 Independent Chairman of Supervisory Board
Michel De Wilde 73 2016 Member of Scientific Advisory Board
Hans-Georg Rammensee - 2001 Scientific Director of Immunology and Member of Scientific Advisory Board
Jean-Paul Prieels - 2016 Member of Scientific Advisory Board
Christopher Karp - 2016 Member of Scientific Advisory Board
Stanley A. Plotkin 91 2016 Member of Scientific Advisory Board
Fred Zepp - 2016 Member of Scientific Advisory Board
Nina Bhardwaj - 2016 Member of Scientific Advisory Board
Mathias P. Hothum 57 2015 Supervisory Board Member
Michael P. Manns - 2016 Member of Scientific Advisory Board
Craig A. Tooman 58 2019 Supervisory Board Member
Daniel Speiser - 2016 Member of Scientific Advisory Board
Xiao-Ning Xu - 2016 Member of Scientific Advisory Board
George R. Siber 79 2016 Member of Scientific Advisory Board
Dirk Jäger - 2016 Member of Scientific Advisory Board
Klaus Schollmeier 67 2022 Supervisory Board Member
Karim Fizazi 58 2016 Member of Scientific Advisory Board
Gerd Zettlmeissl 69 2016 Member of Scientific Advisory Board
Viola Bronsema 60 2020 Supervisory Board Member
Debra Barker 62 2022 Supervisory Board Member
Michael Brosnan 69 2023 Independent Director of Supervisory Board
Craig L. Slingluff - 2023 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CVAC Comments

Write your thoughts about Curevac NV
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Musial Pearson
Musial Pearson Jul 25, 2023 11:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Big Newss coming soon......
damian del
mudlog79 May 09, 2023 6:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
overvalued trash
Despoina Alterlife
Despoina Alterlife Jan 24, 2023 10:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Curevac Vaccine finally approved .!
Nicola Perilli
Nicola Perilli Jan 14, 2023 7:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AT SAT Speriamo che arrivi almerno a 25!
Despoina Alterlife
Despoina Alterlife Jan 14, 2023 7:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when ?
Nicola Perilli
Nicola Perilli Jan 12, 2023 5:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Fiducia  in Curevac. Prima o poi  dara's molta soddisfazione
Al Sat
Al Sat Jan 09, 2023 8:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
First target $25
Nicola Perilli
Nicola Perilli Nov 24, 2022 9:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Penso che sia giunto il momento di acquistare a prezzp scontato le azione della curavac.
Nash Purswani
Nash Purswani Nov 17, 2022 8:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I retract that - keep at it n wish the company success
Nash Purswani
Nash Purswani Nov 17, 2022 8:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Totally incompetent
Despoina Alterlife
Despoina Alterlife Nov 15, 2022 12:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
tomorrow sell off , Don't cry for me Argentinaaaaaa........
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email